Physician profile
Steven Licata
NPI 1508874439
$380.65
in general payments reported to CMS, 2019-2025
7 companies · $87.04 in 2025
The $87.04 reported for 2025 was less than what a typical Neuromusculoskeletal Medicine & Omm provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.47 · 2020: $36.32 · 2021: $49.16 · 2022: $81.99 · 2023: $22.39 · 2024: $54.28 · 2025: $87.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $163.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $92.48 | 2022-2024 | Orthovisc |
| Spr Therapeutics, INC | $87.04 | 2025 | Sprint Pns System |
| Amgen INC. | $84.38 | 2019-2022 | |
| Pacira Therapeutics, INC. | $66.40 | 2019-2020 | |
| Tactile Systems Technology INC | $17.47 | 2024 | Entre Plus, Flexitouch Plus |
| Kowa Pharmaceuticals America, INC. | $16.87 | 2022 | |
| Zimmer Biomet Holdings, INC. | $16.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Licata listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.